MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Sleep, Fatigue and Health-related quality of life in a cohort of Parkinson disease patients

    O. Ojo, N. Okubadejo, O. Odeniyi, N. Osemwegie, O. Oguntunde (Idi-araba, Nigeria)

    Objective: To determine frequencies of non-motor symptoms (NMS) specifically sleep disorders, fatigue and mood disorders in a cohort of Nigerians with PD seen at the…
  • 2018 International Congress

    α-synuclein aggregation and propagation in marmoset brains deteriorates its motor function

    T. Yabumoto, K. Baba, H. Hayakawa, K. Ikenaka, F. Yoshida, T. Uehara, R. Nakatani, H. Tsuda, S. Nagano, H. Hamanaka, Y. Nagai, M. Hirata, H. Mochizuki. (Osaka, Japan)

    Objective: To confirm that α-synuclein aggregation and propagation in marmoset brains deteriorates its motor function. Background: Recently, the α-synuclein amyloid fibril is thought to be…
  • 2018 International Congress

    Deletion of GBA2 in neuronopathic Gaucher’s disease medaka can’t rescue the phenotype

    E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

    Objective: This study was performed to determine the pathological role of GBA2 in the CNS in GD and GBA1-related PD. Background: Parkinson’s disease (PD) is…
  • 2018 International Congress

    Classification of Dopaminergic-State and Motor Activity by Theta, Beta and Gamma Activity in Parkinson’s Disease

    I. Weber, C. Oehrn, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)

    Objective: To test whether machine learning algorithms are suitable to classify dopamine and behavioral states in Parkinson’s patients (PD). Background: While motor symptoms of PD…
  • 2018 International Congress

    Depression and associated factors in nondemented Chinese patients with Parkinson’s disease

    J. Zhu, L. Zhang (Nanjing, China)

    Objective: This study aimed to estimate the prevalence and identify potential risk factors influencing depression in 519 consecutive nondemented Chinese PD patients. Background: Depression is…
  • 2018 International Congress

    Single limb stance test performance – Difference between tremor dominant and akinetic rigid dominant parkinson’s disease – A pilot study

    S. Durairaj, A. Christina, V. Mathew, M. Gowri (Vellore, India)

    Objective: The objective of the study is to compare single-limb stance test performance between tremor dominant (TD) and akinetic rigid dominant (ARD) Parkinson's disease patients.…
  • 2018 International Congress

    Knowledge of Parkinson’s Disease in Urban Population of Kyrgyz Republic

    C. Shambetova, A. Arykova, I. Nisheglotova, B. Abdildaev, SY. Lim, AH. Tan (Bishkek, Kyrgyzstan)

    Objective: To assess public knowledge of Parkinson's disease (PD) in an urban population in Kyrgyz Republic. Background: Poor awareness and knowledge regarding PD among the…
  • 2018 International Congress

    Clinical practice of levodopa in parkinsonism

    AC. Chen (Taichung, Taiwan)

    Objective: This study is for the clinical effect of levodopa in parkinsonism. Background: Levodopa was common used in Parkinson disease. Levodopa induced dyskinesia(LID) is the…
  • 2018 International Congress

    Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: Results from the Phase 3 double-blind, placebo-controlled trial

    S. Factor, S. Isaacson, K. Sciarappa, P. Bhargava, G. Vakili, A. Agro, D. Blum, W. Olanow, B. Navia (Atlanta, GA, USA)

    Objective: To evaluate the efficacy of APL-130277 (APL) in a double-blind, placebo-controlled trial. Background: OFF episodes are a common, disabling complication of Parkinson’s disease (PD)…
  • 2018 International Congress

    Comparison of low versus high frequency stimulation on stuttering in Parkinson’s disease patients with bilateral subthalamic nucleus deep brain stimulation

    O. Jitkritsadakul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)

    Objective: The objective of this study was to identify the prevalence of stuttering in PD patients with bilateral STN DBS compared to medically-treated PD (PD-MED)…
  • « Previous Page
  • 1
  • …
  • 236
  • 237
  • 238
  • 239
  • 240
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley